As governments around the world grapple with the spread of a more virulent variant of the coronavirus — first identified in South Africa — top health officials in the United States said Friday the new coronavirus variants present a “wake-up call” to move faster on vaccinating the population.
Limited vaccine supplies in the European Union undergird much of the region’s restrictions on travel. The E.U.’s regulator on Friday recommended authorization of the Oxford-AstraZeneca coronavirus vaccine as E.U leaders planned to announce details of a new mechanism designed to restrict vaccine exports outside the bloc.
Here are the latest developments:
Press Enter to skip to end of carousel
End of carouselHere's what to know:
Carousel - $Here's what to know:: use tab or arrows to navigate
Canada announced extensive border restrictions that include mandatory testing and quarantine at designated hotels for all returning travelers.
Maryland biotech company Novavax announced that its coronavirus vaccine was highly effective in preventing illness — except against the B.1351 variant.
E.U. regulators have authorized the AstraZeneca vaccine for adults despite a lack of data on its efficacy in older adults.
The European Commission has published its contract with drugmaker AstraZeneca after a heated dispute over production delays.
1/4